US Stocks
/
Monopar Therapeutics Inc. Share Price

Monopar Therapeutics Inc. Share Price

NASDAQ: MNPR
$96.56
-$5.74 (-5.61%) Last updated on 19 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Monopar Therapeutics Inc. Stock Performance

Open
$100.91
Prev. Close
$102.30
Circuit Range
N/A
Day Range
$95.95 - $100.91
Year Range
$50.33 - $123.95
Volume
5,597
Average Traded
$97.95

Monopar Therapeutics Inc. Share Price Today

As of 19 September 2026, Monopar Therapeutics Inc.'s share price is $96.56. The stock opened at $100.91, compared to its previous close of $102.30. During today's trading session, Monopar Therapeutics Inc.'s share price traded between $95.95 and $100.91, with an average price of $98.43. Over the past 52 weeks, the stock has recorded a high of $123.95 and a low of $50.33. In terms of performance, Monopar Therapeutics Inc.'s share price has risen by 75.55% over the last six months and is up 19.74% on a year-on-year basis.

Monopar Therapeutics Inc. Share Price Chart

$95.95$100.91
L
Show Current Price
H

Monopar Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
-163.56%

Monopar Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$1.64M-$1.72M-$1.30M-$2.62M-$2.45M-$3.44M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-4.51%23.96%-101.26%6.53%-40.11%

Monopar Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars2021202220232024
RevenueN/AN/AN/AN/A
Net Profit-$9.10M-$10.52M-$8.40M-$15.59M
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-15.52%20.10%-85.50%

About Monopar Therapeutics Inc.

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, a clinical-stage radiodiagnostic imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a late-preclinical stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19. The company was founded in 2014 and is headquartered in Wilmette, Illinois.

Monopar Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$113.19
$97.20
-15.35%
Aug 2026
$107.40
$114.82
+6.10%
Jul 2026
$95.57
$108.22
+17.05%
Jun 2026
$65.00
$92.46
+42.80%
May 2026
$51.35
$64.75
+22.84%
Apr 2026
$56.07
$52.71
-4.16%
Mar 2026
$53.38
$55.00
+0.25%
Feb 2026
$62.62
$54.87
-9.77%
Jan 2026
$66.06
$60.80
-6.57%
Dec 2025
$82.99
$65.08
-24.01%
Nov 2025
$80.51
$85.65
-0.06%
Oct 2025
$83.00
$85.70
+6.27%

MNPR Share Price FAQs

What is Monopar Therapeutics Inc. share price today?

chevron-up
Monopar Therapeutics Inc. share price today is $96.56 as on September 19, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Monopar Therapeutics Inc. stock?

chevron-up
The 52 week high of Monopar Therapeutics Inc. stock is $123.95, while the 52 week low is $50.33 as of 19 Sep '26.

What is MNPR's net income for the last quarter?

chevron-up
MNPR's net income for the last quarter is -0.00B USD.

What is the 5 year returns of MNPR?

chevron-up
The 5 year returns of MNPR is 296.53% as on 19 Sep '26.

What is the high & low stock price of MNPR today?

chevron-up
MNPR stock price hit a high of $100.91 and low of $95.95 as of 19 Sep '26.

Can I buy MNPR shares in India?

chevron-up
Yes. You can buy MNPR in India by opening an international trading account.